Dr William N Bernhard, MD | |
2624 Fairview Pt Rd. Bldg E 6814, Aviation Medicine Clinic, Edgewood (apg), MD 21040 | |
(410) 436-6570 | |
(410) 436-6598 |
Full Name | Dr William N Bernhard |
---|---|
Gender | Male |
Speciality | Preventive Medicine - Occupational Medicine |
Location | 2624 Fairview Pt Rd. Bldg E 6814, Edgewood (apg), Maryland |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1467505362 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
2083X0100X | Preventive Medicine - Occupational Medicine | D00006476 (Maryland) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr William N Bernhard, MD 1430 Carpenters Point Rd, Perryville, MD 21903-2015 Ph: (410) 642-3111 | Dr William N Bernhard, MD 2624 Fairview Pt Rd. Bldg E 6814, Aviation Medicine Clinic, Edgewood (apg), MD 21040 Ph: (410) 436-6570 |
News Archive
Lung Cancer Alliance received the Leadership in Advocacy Award at today's forum of the Congressional Black Caucus Health Braintrust in Washington D.C.
Olivier De Schutter, the U.N. special rapporteur on the right to food, writes in a Guardian opinion piece, "In order to support investment in agriculture, governments have ... come to rely on private sector investment and development aid - and increasingly a partnership of the two," and he notes "the New Alliance for Food Security and Nutrition, proposed by U.S. President Barack Obama and the U.S. Agency for International Development and launched in May 2012, will draw more than $3 billion of private sector investment into food security plans in Africa."
Researchers at Harvard Medical School have discovered that structural elements in the cell play a crucial role in organizing the motion of cell-surface receptors, proteins that enable cells to receive signals from other parts of the organism.
Researchers from VTT Technical Research Centre of Finland have in collaboration with the University of Turku, Indiana University and two Finnish companies, Biotie Therapies Corp. and Pharmatest Services Ltd, discovered a novel mechanism regulating the development of breast cancer bone metastases and showed that heparin-like compounds can potentially be used to inhibit breast cancer metastasis to bone.
An hour can make the difference between life and death when using tranexamic acid to treat injured patients with severe bleeding, a study by researchers at the London School of Hygiene & Tropical Medicine suggests.
› Verified 6 days ago